Biological Mechanisms Underlying Objective Responses in Recurrent GBM Patients Treated with Sequential Bortezomib and Temozolomide: an Interim Analysis of NCT03643549 Phase IB/II Trial
CANCER RESEARCH（2024）
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要